These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17344113)

  • 1. [Glycaemic control and macrovascular complications in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2007 Jan; 148(1):17-20. PubMed ID: 17344113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular complications of diabetes.
    Lau DC; Shen GX
    Can J Diabetes; 2013 Oct; 37(5):279-81. PubMed ID: 24500552
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus.
    Mattila TK; de Boer A
    Drugs; 2010 Dec; 70(17):2229-45. PubMed ID: 21080740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
    Stettler C; Allemann S; Jüni P; Cull CA; Holman RR; Egger M; Krähenbühl S; Diem P
    Am Heart J; 2006 Jul; 152(1):27-38. PubMed ID: 16824829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of macrovascular complications of type 2 diabetes mellitus with serum magnesium levels.
    Agrawal P; Arora S; Singh B; Manamalli A; Dolia PB
    Diabetes Metab Syndr; 2011; 5(1):41-4. PubMed ID: 22814841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.
    Nalysnyk L; Hernandez-Medina M; Krishnarajah G
    Diabetes Obes Metab; 2010 Apr; 12(4):288-98. PubMed ID: 20380649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.
    Tkác I
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S57-62. PubMed ID: 20115934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low glucose blood levels are associated with abnormal cardiac sympatho-vagal balance in type 2 diabetic patients with coronary artery disease.
    Infusino F; Pitocco D; Zaccardi F; Scalone G; Coviello I; Nerla R; Mollo R; Sestito A; Di Monaco A; Barone L; Pisanello C; Ghirlanda G; Lanza GA; Crea F
    Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):203-7. PubMed ID: 20391959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic variability in the development of cardiovascular complications in diabetes.
    Nusca A; Tuccinardi D; Albano M; Cavallaro C; Ricottini E; Manfrini S; Pozzilli P; Di Sciascio G
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3047. PubMed ID: 30028067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus: biological determinants of atherosclerosis and restenosis.
    Marso SP; Mak KH; Topol EJ
    Semin Interv Cardiol; 1999 Sep; 4(3):129-43. PubMed ID: 10545619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and macrovascular disease.
    Miettinen H; Salomaa V
    Coron Artery Dis; 1996 Oct; 7(10):708-14. PubMed ID: 8970761
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
    J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
    Ma J; Yang W; Fang N; Zhu W; Wei M
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Metabolic Syndrome and Microvascular and Macrovascular Disease in Type 2 Diabetic Mellitus.
    Lee MY; Hsiao PJ; Huang JC; Hsu WH; Chen SC; Shin SJ
    Am J Med Sci; 2018 Apr; 355(4):342-349. PubMed ID: 29661347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of metabolic risk factors on the presence of carotid artery disease in patients with type 2 diabetes and coronary artery disease.
    Bosevski M; Borozanov V; Georgievska-Ismail L
    Diab Vasc Dis Res; 2007 Mar; 4(1):49-52. PubMed ID: 17469044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose control and cardiovascular disease: is it important? No.
    Conget I; Giménez M
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S334-6. PubMed ID: 19875576
    [No Abstract]   [Full Text] [Related]  

  • 19. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular wall and diabetes mellitus: what complications and why?].
    Marre M
    Therapie; 1997; 52(5):371-4. PubMed ID: 9501559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.